Addressing Bias: Utilizing emerging therapeutics amidst fat-shaming
Rising rates of obesity and diabetes, drug shortages, patient demand and societal discussions around fat-shaming, have placed family physicians in a difficult position, at times acting as gatekeepers for medications, determining which patients should gain access to GLP-1 agonists. Broader societal discussion around what constitutes ‘health’ and ‘overweight’ may leave physicians feeling alone in grappling with these ethical decisions. Watch our panel as they address their approach as stewards of these medications and share how they engage in these larger societal discussions. The Practising Well Community of Practice has been certified by the College of Family Physicians of Canada and the Ontario Chapter for up to 1 Mainpro+Ⓡcredits. This Community of Practice includes a series of planned webinars. Each session is worth 1 Mainpro+Ⓡcredits, for up to a total of 12 credits. Panelists: Co-host: Moderator: Download the resources: Session slides (PDF) Resources (PDF) Watch this session: Listen to this session: Self-learning program: This session is part of the Practising Well Self Learning Program. Visit the Self Learning Program page to learn more and to participate. Need more information? Join Peer Connect for more individualized, educational support on this topic.